Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glucose Health is a publicly traded consumer healthcare company that develops and markets functional beverages specifically for the diabetic and pre-diabetic populations. The company's flagship brand, GlucoDown, features a range of flavored drink mixes infused with clinical-grade soluble fiber and micronutrients like chromium picolinate. These products are formulated to assist in maintaining healthy blood sugar levels and supporting metabolic health without the use of added sugars. Glucose Health distributes its products through major national retailers, including Walmart and Amazon, targeting the significant demographic of individuals managing glucose levels. The company operates within the nutraceutical sector, bridging the gap between traditional supplements and functional foods. Its business model focuses on high-volume retail distribution and brand expansion within the metabolic health category.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glucose Health.